Krsnaa Diagnost. Q1 FY27 Share Price & Earnings Call Analysis

Financials of Krsnaa Diagnost.

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Krsnaa Diagnost.

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +116132147152159163179165175176183159173
Expenses +91100116113116120126117121126125112116
Operating Profit25323138434352485350584857
OPM %22%24%21%25%27%26%29%29%31%29%32%30%33%
Other Income +64444759444431
Interest22347566768812
Depreciation15161821182122232222232322
Profit before tax14191417222428282926312154
Tax %17%18%20%20%17%23%23%24%28%26%24%22%20%
Net Profit +12151114181822222120231643
EPS in Rs3.764.863.604.215.705.636.806.696.536.037.165.0813.37

Financials of Krsnaa Diagnost.

Profit & Loss

Annual income statement trend

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +3657108147258396455464590682691
Expenses +354216987373302320340444485478
Operating Profit015-6260-11494135124146197213
OPM %1%26%-57%41%-44%24%30%27%25%29%31%
Other Income +3432132651519172643
Interest668162526188162534
Depreciation510182632374154758890
Profit before tax-72-8421-158295908272110132
Tax %6%8%-29%40%-29%37%21%23%19%24%22%
Net Profit +-82-6012-11218571645983103
EPS in Rs-15.054.01-116.5424.15-216.83284.7322.5220.2318.1425.6531.65
Dividend Payout %0%0%0%0%0%0%11%14%14%11%0%

Financials of Krsnaa Diagnost.

Balance Sheet

Capital structure and asset base

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital555561616161616
Reserves4643-217-17671727799877976
Borrowings +1311023302464744132160202531
Other Liabilities +2463115596146149134197188295
Total Liabilities1631764936306098779091,1721,2831,818
Fixed Assets +59116223275309386471647668651
CWIP20642942825103208
Investments000000003258
Other Assets +8553228345297463413514581902
Total Assets1631764936306098779091,1721,2831,818

Financials of Krsnaa Diagnost.

Cash Flows

Operating, investing and financing cash movement

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +596138119129752489134
Cash from Investing Activity +-53-201-77-67-241-109-129-102-391
Cash from Financing Activity +-37145620176-338414278
Net Cash Flow-314-337164-66-20122
Free Cash Flow6-42-3950-2-59-169-21-80
CFO/OP410%114%-42%134%100%71%30%55%75%

Financials of Krsnaa Diagnost.

Ratios

Working capital efficiency and return ratios

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days879114087694859110152163
Inventory Days21248954
Days Payable7699878119
Cash Conversion Cycle3215-6508769485911015298
Working Capital Days-428-119-234-133-82-2116-182866
ROCE %7%-65%129%18%12%10%13%13%

Others in Healthcare Services this season

  • Metropolis Healt (Q1 FY27)

    East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…

  • Apollo Hospitals (Q1 FY27)

    IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…

  • Health X Platform Ltd (Q1 FY27)

    July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…

  • Shalby Ltd (Q1 FY27)

    Shalby MedTech showed strong revenue growth: ₹47 crores in Q1 FY27, a 53% YoY increase. Key concall takeaways from Shalby Ltd's Q1 FY27 earnings call — and how…

Compare:vs Apollo Hospitalsvs Max Healthcare Institute Ltdvs Fortis Health.